Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life
Abstract
:1. Introduction
2. Materials and Methods
2.1. Subjects
2.2. Assessment of Disease Specific Knowledge
2.3. Health-Related Quality of Life of Patients and Emotional Wellbeing of Parents
2.4. The Medication Level Variability Index (MLVI)
2.5. Statistical Analysis
2.6. Ethical Considerations
3. Results
3.1. Parental Disease-Specific Knowledge
3.2. Self-Estimation of Disease-Specific Knowledge
3.3. Is the Quality of Parental Disease-Specific Knowledge Associated with Outcome?
3.3.1. MLVI and Rejection
3.3.2. Psychosocial Outcome
3.4. Which Other Factors Affect Knowledge and Psychosocial Outcome?
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kerkar, N.; Danialifar, T. Changing definitions of successful outcomes in pediatric liver transplantation. Curr. Opin. Organ. Transplant. 2014, 19, 480–485. [Google Scholar] [CrossRef] [PubMed]
- Ng, V.; Nicholas, D.; Dhawan, A.; Yazigi, N.; Ee, L.; Stormon, M.; Gilmour, S.; Schreiber, R.; Taylor, R.; Otley, A.; et al. Development and validation of the pediatric liver transplantation quality of life: A disease-specific quality of life measure for pediatric liver transplant recipients. J. Pediatr. 2014, 165, 547–555.e7. [Google Scholar] [CrossRef] [PubMed]
- Nicholas, D.B.; Otley, A.R.; Taylor, R.; Dhawan, A.; Gilmour, S.; Ng, V.L. Experiences and barriers to Health-Related Quality of Life following liver transplantation: A qualitative analysis of the perspectives of pediatric patients and their parents. Health Qual. Life Outcomes 2010, 8, 150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Blote, R.; Memaran, N.; Borchert-Morlins, B.; Thurn-Valsassina, D.; Goldschmidt, I.; Beier, R.; Sauer, M.; Müller, C.; Sarganas, G.; Oh, J.; et al. Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant Recipients. Transplantation 2019, 103, 2423–2433. [Google Scholar] [CrossRef]
- Memaran, N.; Borchert-Morlins, B.; Schmidt, B.M.W.; Sugianto, R.I.; Wilke, H.; Blote, R.; Baumann, U.; Bauer, E.; von Wick, A.; Junge, N.; et al. High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation. Liver Transplant. 2019, 25, 752–762. [Google Scholar] [CrossRef]
- Wallot, M.A.; Mathot, M.; Janssen, M.; Holter, T.; Paul, K.; Buts, J.P.; Reding, R.; Otte, J.B.; Sokal, E.M. Long-term survival and late graft loss in pediatric liver transplant recipients—A 15-year single-center experience. Liver Transplant. 2002, 8, 615–622. [Google Scholar] [CrossRef]
- Mayer, K.; Junge, N.; Goldschmidt, I.; Leiskau, C.; Becker, T.; Lehner, F.; Richter, N.; van Dick, R.; Baumann, U.; Pfister, E.-D. Psychosocial outcome and resilience after paediatric liver transplantation in young adults. Clin. Res. Hepatol. Gastroenterol. 2019, 43, 155–160. [Google Scholar] [CrossRef] [Green Version]
- Miserachs, M.; Parmar, A.; Bakula, A.; Hierro, L.; D’Antiga, L.; Goldschmidt, I.; Debray, D.; McLin, V.A.; Casotti, V.; Pawłowska, J.; et al. Health-related quality of life in pre-adolescent liver transplant recipients with biliary atresia: A cross-sectional study. Clin. Res. Hepatol. Gastroenterol. 2019, 43, 427–435. [Google Scholar] [CrossRef]
- Dobbels, F.; Van Damme-Lombaert, R.; Vanhaecke, J.; De Geest, S. Growing pains: Non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr. Transplant. 2005, 9, 381–390. [Google Scholar] [CrossRef]
- Shemesh, E.; Duncan, S.; Anand, R.; Shneider, B.L.; Alonso, E.M.; Mazariegos, G.V.; Venick, R.S.; Annunziato, R.A.; Bucuvalas, J.C. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: The medication adherence in children who had a liver transplant cohort. Liver Transplant. 2018, 24, 80–88. [Google Scholar] [CrossRef]
- Couch, R.; Jetha, M.; Dryden, D.M.; Hooten, N.; Liang, Y.; Durec, T.; Sumamo, E.; Spooner, C.; Milne, A.; O’Gorman, K.; et al. Diabetes education for children with type 1 diabetes mellitus and their families. Evid. Rep. Technol. Assess 2008, 166, 1–144, PMID: 18620470; PMCID: PMC4781150. [Google Scholar]
- Ersser, S.J.; Latter, S.; Sibley, A.; Satherley, P.A.; Welbourne, S. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst. Rev. 2014, 2014, CD004054. [Google Scholar] [CrossRef]
- Ernst, G.; Menrath, I.; Lange, K.; Eisemann, N.; Staab, D.; Thyen, U.; Szczepanski, R.; ModuS Study Group. Development and evaluation of a generic education program for chronic diseases in childhood. Patient Educ. Couns. 2017, 100, 1153–1160. [Google Scholar] [CrossRef]
- Lange, K.; Ernst, G. Umgang mit Chronisch Kranken Kindern und Jugendlichen. Psychologische und Pädagogische Elemente der Langzeitbehandlung. In Pädiatrische Endokrinologie und Diabetologie, 2nd ed.; Hiort, T., Danne, T., Wabitsch, M., Eds.; Springer: Berlin/Heidelberg, Germany; New York, NY, USA, 2017. [Google Scholar]
- Menrath, I.; Ernst, G.; Lange, K.; Eisemann, N.; Szczepanski, R.; Staab, D.; Degner, M.; Thyen, U.; ModuS Study Group. Evaluation of a generic patient education program in children with different chronic conditions. Health Educ. Res. 2019, 34, 50–61. [Google Scholar] [CrossRef]
- Lerret, S.M.; Weiss, M.E.; Stendahl, G.L.; Chapman, S.; Menendez, J.; Williams, L.; Nadler, M.L.; Neighbors, K.; Amsden, K.; Cao, Y.; et al. Pediatric solid organ transplant recipients: Transition to home and chronic illness care. Pediatr. Transplant. 2015, 19, 118–129. [Google Scholar] [CrossRef] [Green Version]
- Goldbeck, L.S.; Storck, M. A quality of life inventory for parents of chronically ill children. Z. Klin. Psychol. Psychother. 2002, 31, 31–39. [Google Scholar] [CrossRef]
- Weissberg-Benchell, J.; Zielinski, T.E.; Rodgers, S.; Greenley, R.N.; Askenazi, D.; Goldstein, S.L.; Fredericks, E.M.; McDiarmid, S.; Williams, L.; Limbers, C.A.; et al. Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module. Am. J. Transplant. 2010, 10, 1677–1685. [Google Scholar] [CrossRef] [Green Version]
- Shemesh, E.; Bucuvalas, J.C.; Anand, R.; Mazariegos, G.V.; Alonso, E.M.; Venick, R.S.; Reyes-Mugica, M.; Annunziato, R.A.; Shneider, B.L. The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study. Am. J. Transplant. 2017, 17, 2668–2678. [Google Scholar] [CrossRef]
- Fredericks, E.M.; Lopez, M.J.; Magee, J.C.; Shieck, V.; Opipari-Arrigan, L. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am. J. Transplant. 2007, 7, 1974–1983. [Google Scholar] [CrossRef] [Green Version]
- Shemesh, E.; Shneider, B.L.; Savitzky, J.K.; Arnott, L.; Gondolesi, G.E.; Krieger, N.R.; Kerkar, N.; Magid, M.S.; Stuber, M.L.; Schmeidler, J.; et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004, 113, 825–832. [Google Scholar] [CrossRef]
- Almgren, M.; Lundqvist, P.; Lennerling, A.; Forsberg, A. Self-efficacy, recovery and psychological wellbeing one to five years after heart transplantation: A Swedish cross-sectional study. Eur. J. Cardiovasc. Nurs. 2021, 20, 34–39. [Google Scholar] [CrossRef]
Patients (n = 113) | n (%) | Parents (n = 113) | n (%) |
---|---|---|---|
Sex | Primary caregiver’s marital status | ||
Male | 45 (39.8) | information missing | 4 (3.5) |
Female | 68 (60.2) | Single-parent household | 14 (12.4) |
Age at study entry (years) | Two-parent household | 95 (84.1) | |
Mean SD | 9.21 ± 4.87 | Primary caregiver’s highest level of education | |
Median Min, Max | 8.67 0.50, 18.25 | information missing | 4 (3.5) |
Transplantation status | No degree | 2 (1.8) | |
awaiting transplant | 25 (22.1) | General certificate | 12 (10.6) |
after liver transplantation | 88 77.8) | Secondary school | 48 (42.5) |
Age at transplant | Highschool | 25 (22.1) | |
<1 year | 38 (43.2) | University education | 22 (19.5) |
1–4 years | 32 (36.4) | Native language | |
5–12 years | 17 (19.3) | German | 82 (72.6) |
13–17 years | 1 (1.1) | other | 27 (23.9) |
Time since transplant (years) | information missing | 4 (3.5) | |
Mean (SD) | 7.45 ± 4.53 | ||
Median Min, Max | 7.17 0.00, 17.00 | ||
Primary diagnosis | |||
Biliary atresia | 70 (61.9) | ||
PFIC | 5 (4.4) | ||
Acute liver failure | 10 (8.8) | ||
Metabolic | 4 (3.5) | ||
Tumor | 6 (5.3) | ||
Autoimmune Hepatitis | 1 (0.9) | ||
Other | 13 (11.5) |
Multiple Choice Questions (4 Possible Answers, Multiple Selection Possible) | Frequency of Correct Answers (%) | I Do Not Know Frequency (%) | |
---|---|---|---|
Which functions of the liver do you know? | 81 | 3.5 | |
What is the bile’s function? | 74 | 9.2 | |
What are warning signs for biliary tract infection? | 77.5 | 4.5 | |
What is abdominal dropsy? | 62.5 | 18.3 | |
What does the term “liver remodeling” mean? | 77.0 | 16.4 | |
What does cholestasis mean? | 66.5 | 27.0 | |
What is portal hypertension? | 48.8 | 29.1 | |
What can happen in portal hypertension? | 38.5 | 43.1 | |
In case of which diseases in the immediate environment of the child (family, school, day care) should you report to your transplant team? | 69.3 | 18.9 | |
Which possible side effects of immunosuppressive drugs do you know? | 58.8 | 23.4 | |
Which statements concerning the liver transplant waiting list are correct? | 77.0 | 8.1 | |
Individual Statements to Be Marked as True or False | Correct Answer Frequency (%) | Wrong Answer Frequency (%) | I Do Not Know Frequency (%) |
My child must reach a certain age to be able to get a new liver. | 91.0 | 0.9 | 8.1 |
Children who have been on the transplant waiting list the longest get a new liver first. | 77.1 | 10.1 | 12.8 |
The children who need a new liver most urgently get a new liver first. | 80.7 | 10.1 | 9.2 |
It is possible that a child receives an organ offer although another child has more points on the waiting list. | 56.9 | 11.9 | 31.2 |
My child should be as fully vaccinated as possible before transplantation. | 77.1 | 11.0 | 11.9 |
Any vaccination may be performed immediately after transplantation. | 81.1 | 4.5 | 14.4 |
Inactivated vaccines may be used from one year after transplantation | 61.5 | 4.6 | 33.9 |
The majority of organ donations are cadaveric donations from patients who have been diagnosed with brain death. | 58.7 | 4.6 | 36.7 |
There is a possibility that a relative donates a part of his/her liver. | 96.4 | 0 | 3.6 |
The immunosuppressive drugs are needed to prevent the patient’s own immune system from attacking the “new liver”. | 91.7 | 0.9 | 7.3 |
The immunosuppressive drugs must be taken for the whole life. | 82.9 | 1.8 | 15.3 |
The immunosuppressants should be taken during meals. | 71.4 | 3.6 | 25.0 |
Immunosuppression leads to an increased susceptibility to infections. | 73.9 | 0.9 | 18.9 |
The immunosuppressive drug trough level is important because it determines the dose that must be taken. | 82.9 | 0.9 | 16.2 |
If the drug trough level is too high, there is a risk of rejection. | 45.5 | 17.3 | 37.3 |
My child is not allowed to eat before blood is drawn to determine the level of immunosuppressants. | 57.7 | 21.6 | 20.7 |
My child must not take his immunosuppressive drugs before blood is drawn to determine the drug trough level. | 76.6 | 3.6 | 19.8 |
In case of “rejection” the immune system reacts to the “new liver”. | 81.1 | 0.9 | 18.0 |
Rejection means that the transplanted organ is lost. | 64.0 | 17.1 | 18.9 |
Rejection may be related to too much immunosuppression. | 41.4 | 8.1 | 50.5 |
It is sufficient if my child goes for a medical checkup once a year. | 78.4 | 7.2 | 14.4 |
After transplantation, my child is entitled to a severely disabled person’s card. | 80.4 | 4.6 | 15.0 |
My child must never do sports again after transplantation. | 91.1 | 0.9 | 8.0 |
How Would You Rate Your Level of Knowledge on the Following Topics? | Mean Likert Scale Result |
---|---|
Illness of your child | 3.96 ± 0.7 |
Anatomy of the liver (portal vein, bile ducts, etc.) | 3.30 ± 0.8 |
Functions of the liver | 3.42 ± 0.8 |
Technical terms such as liver remodeling, tarry stools, portal hypertension, etc. | 3.17 ± 0.9 |
Proceedings during an inpatient stay | 3.77 ± 1.0 |
Transplantation | 3.51 ± 1.0 |
Proceedings before liver transplantation | 3.37 ± 1.1 |
Proceedings during the in-patient stay for liver transplantation | 3.5 ± 1.1 |
Proceedings after liver transplantation | 3.55 ± 1.1 |
Meaning of laboratory values | 3.42 ± 0.9 |
Medication of your child | 4.09 ± 0.7 |
Immunosuppressants of your child | 3.81 ± 1.2 |
Diagnostic procedures, e.g., ultrasound, MRI, X-ray | 3.75 ± 0.8 |
Everyday life with the disease | 4.04 ± 0.8 |
Psychological support options | 2.95 ± 0.9 |
Possible assistance for the care of your child (e.g., care allowance, severely handicapped certificate, etc.) | 3.10 ± 1.1 |
Importance of nutrition | 3.60 ± 0.9 |
Topic Areas | |
Basic knowledge on liver and liver disease (a–d) | 3.46 ± 0.7 |
Transplantation (e–i) | 3.54 ± 0.9 |
Medication (k, l) | 3.96 ± 0.8 |
Follow-up care (j, m–q) | 3.49 ± 0.6 |
ULQUI Subscale | Subscale Summary Score |
---|---|
Physical and daily functioning | 68.0 |
Satisfaction with family life | 83.1 |
Emotional burden | 67.3 |
Self realisation | 50.3 |
General wellbeing | 71.4 |
ULQUI total score | 67.4 |
PedsQL Transplant Module Subscales | Subscale Summary Score |
---|---|
About his/her medicines I | 86.2 |
About his/her medicines II (side effects) | 87.1 |
Transplant and Others | 74.9 |
Pain and Hurt | 79.1 |
Worry | 80.8 |
Treatment anxiety | 69.7 |
Preceived physical appearance | 79.9 |
Communication | 74.9 |
PedsQL total score | 80.5 |
Knowledge Test Result | Liver Function and Liver Disease | Transplantation | Medication | Follow-Up Care | |
---|---|---|---|---|---|
PedsQL transplant module | About his/her Medicines I | −0.02 | 0.11 | 0.03 | 0.09 |
About his/her Medicines II | −0.16 | −0.07 | −0.26 * | −0.2 | |
Transplant and others | −0.07 | 0.01 | −0.07 | −0.04 | |
Pain and Hurt | −0.17 | −0.09 | −0.25 * | −0.22 * | |
Worry | −0.01 | 0.01 | −0.06 | 0.02 | |
Treatment anxiety | −0.08 | −0.01 | −0.19 | −0.21 * | |
Perceived physical Appearance | −0.21 | −0.01 | −0.16 | −0.02 | |
Communication | −0.09 | 0.03 | −0.06 | −0.13 | |
PedsQL Total score | −0.13 | −0.01 | −0.17 | −0.12 | |
Self-Assessment of Knowledge | Liver Function and Liver Disease | Transplantation | Medication | Follow-Up Care | |
PedsQL transplant module | About his/her Medicines I | 0.22 * | 0.39 ** | 0.34 ** | 0.31 ** |
About his/her Medicines II | 0.04 | 0.14 | 0.15 | 0.25 * | |
Transplant and others | 0.13 | 0.17 | 0.17 | 0.20 | |
Pain and Hurt | 0.03 | 0.09 | 0.02 | 0.01 | |
Worry | 0.08 | 0.20 | 0.04 | 0.21 | |
Treatment anxiety | 0.15 | 0.24 * | 0.18 | 0.33 | |
Perceived phyiscal Appearance | −0.02 | 0.06 | 0.07 | 0.17 | |
Communication | 0.04 | 0.12 | 0.09 | 0.24 * | |
PedsQL Total score | 0.14 | 0.27 ** | 0.22 * | 0.33 ** |
Knowledge Test Result | Liver Function and Liver Disease | Transplantation | Medication | Follow-Up Care | |
---|---|---|---|---|---|
ULQUI | Physical/daily functioning | 0.06 | 0.08 | −0.03 | 0.01 |
Satisfaction with family life | −0.05 | 0.01 | −0.11 | −0.04 | |
Emotional burden | −0.03 | 0.10 | −0.07 | −0.06 | |
Self realisation | −0.01 | −0.22 * | −0.17 | −0.21 * | |
General well-being | 0.09 | 0.05 | −0.04 | −0.05 | |
ULQI Total score | −0.04 | −0.04 | −0.15 | −0.13 | |
Self-Assessment of Knowledge | Liver Function and Liver Disease | Transplantation | Medication | Follow-Up Care | |
ULQUI | Physical/daily functioning | 0.14 | 0.08 | 0.19 | 0.25 ** |
Satisfaction with family life | 0.02 | 0.07 | 0.15 | 0.23 * | |
Emotional burden | 0.09 | 0.02 | 0.04 | 0.15 | |
Self realisation | 0.05 | −0.02 | 0.03 | 0.02 | |
General well-being | 0.12 | 0.09 | 0.15 | 0.2 * | |
ULQI Total score | 0.09 | 0.04 | 0.11 | 0.21 * |
PedsQL | Upper Tertile Estimated Knowledge Score | Lower Two Tertiles Estimated Knowledge Score | p |
---|---|---|---|
About his/her Medicines I | 91.0 ± 10.6 | 83.0 ± 12.7 | <0.01 |
About his/her Medicines II | 90.8 ± 8.7 | 84.7 ± 15.0 | 0.02 |
Transplant and others | 79.5 ±14.3 | 71.7 ± 15.7 | 0.02 |
Pain and Hurt | 80.3 ± 20.1 | 78.4 ± 19.3 | n.s.* |
Worry | 85.7 ± 17.1 | 77.7 ± 20.9 | n.s. |
Treatment anxiety | 79.2 ± 25.5 | 63.8 ± 29.6 | 0.01 |
Perceived phyiscal Appearance | 82.4 ± 19.8 | 77.7 ± 25.2 | n.s. |
Communication | 81.1 ± 23.0 | 71.0 ± 25.8 | n.s. |
PedsQL Total score | 85.0 ± 10.7 | 77.4 ± 11.6 | <0.01 |
ULQUI | |||
Physical/daily functioning | 72.9 ± 17.1 | 65.3 ± 17.1 | 0.03 |
Satisfaction with family life | 89.1 ± 11.4 | 79.8 ± 17.7 | <0.01 |
Emotional burden | 70.1 ± 22.6 | 65.8 ± 19.5 | n.s. |
Self realisation | 53.6 ± 23.3 | 48.6 ± 22.4 | n.s. |
General well-being | 75.8 ± 17.9 | 69.1 ± 17.1 | n.s. |
ULQI Total score | 70.1 ± 16.7 | 65.4 ± 15.4 | n.s. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stasch, L.; Ohlendorf, J.; Baumann, U.; Ernst, G.; Lange, K.; Konietzny, C.; Pfister, E.-D.; Sautmann, K.; Goldschmidt, I. Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life. Children 2022, 9, 98. https://doi.org/10.3390/children9010098
Stasch L, Ohlendorf J, Baumann U, Ernst G, Lange K, Konietzny C, Pfister E-D, Sautmann K, Goldschmidt I. Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life. Children. 2022; 9(1):98. https://doi.org/10.3390/children9010098
Chicago/Turabian StyleStasch, Luisa, Johanna Ohlendorf, Ulrich Baumann, Gundula Ernst, Karin Lange, Christiane Konietzny, Eva-Doreen Pfister, Kirsten Sautmann, and Imeke Goldschmidt. 2022. "Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life" Children 9, no. 1: 98. https://doi.org/10.3390/children9010098
APA StyleStasch, L., Ohlendorf, J., Baumann, U., Ernst, G., Lange, K., Konietzny, C., Pfister, E. -D., Sautmann, K., & Goldschmidt, I. (2022). Parental Disease Specific Knowledge and Its Impact on Health-Related Quality of Life. Children, 9(1), 98. https://doi.org/10.3390/children9010098